Inovio to participate in upcoming investor conferences in may

Plymouth meeting, pa. , april 29, 2024 /prnewswire/ -- inovio (nasdaq: ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-related diseases, cancer, and infectious diseases, today announced that management will participate in the following investor conferences during the month of may: the citizens jmp life sciences conference date: tuesday, may 14, 2024 time: 11:30 am et presenter: dr. jacqueline shea, president & ceoformat: fireside chat rbc capital markets 2024 global healthcare conference date: wednesday, may 15, 2024 time: 10:00 am et presenter: dr. jacqueline shea, president & ceoformat: fireside chat h.c.
INO Ratings Summary
INO Quant Ranking